Global Med Technologies(R), Inc. Submits ElDorado Donor Doc(TM) to FDA
March 12 2007 - 10:00AM
PR Newswire (US)
- First Modules of ElDorado(TM) Included in Electronic Health
History Software Submission - DENVER, March 12
/PRNewswire-FirstCall/ -- Wyndgate Technologies(R), a division of
Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB)
, announced today that it has submitted a 510(k) for its ElDorado
Donor Doc(TM) software for clearance by the U.S. Food and Drug
Administration (FDA). ElDorado Donor Doc is currently not for sale
in the U.S., pending 510(k) clearance by the FDA. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) Donor
Doc is an electronic health history questionnaire and physical exam
tracking system intended to assist blood donor centers with
screening donors and capturing relevant medical information. This
software has been designed to automate screening processes to
provide data quality assurance and supporting regulatory
compliance. The software is intended to interface with central
blood management systems, to allow easy access to donation
information, to identify missing or suspect data, to record
physical exam results, as well as to capture digital signatures and
donor photographs. This software is also intended to allow donors
to self-administer electronic questionnaires at their own pace,
with options such as audio or text in their own language and
graphics to help convey the meaning of a question. Donor Doc was
designed with significant input from the blood bank industry and
Wyndgate customers. The company organized a technology work group
consisting of leading industry representatives from around the
world during development and beta testing of the software. Michael
I. Ruxin, M.D., Chairman and CEO of Global Med Technologies,
commented, "Global Med Technologies and Wyndgate Technologies are
pleased to have submitted Donor Doc for FDA 510(k) clearance. We
continue to strive to deliver products that our customers request
and need. We appreciate the contributions of our customers to all
of our products, and we are confident in the quality and
functionality of Donor Doc. Our technology work group has been
invaluable throughout this process, and we thank them. We look
forward to the response from the FDA regarding clearance for Donor
Doc." About Global Med Technologies, Inc. Global Med Technologies,
Inc. is an international e-Health medical information technology
company providing information management software products and
services to the healthcare industry. Its Wyndgate Technologies
division is a leading supplier of information management systems to
U.S. and international blood centers and hospital transfusion
centers. Each year, Wyndgate's products and services manage more
than eight million blood components, representing over 27% of the
U.S. blood supply. Wyndgate's products are being used in Canada and
sub-Saharan Africa, and are being implemented in the Caribbean.
Together, the SafeTrace Tx(R)* advanced transfusion management
system and the SafeTrace(R) donor management system provide
Vein-to-Vein(R) tracking from donor collection to patient
transfusion. For more information about Global Med's products and
services, please call 800-WYNDGATE or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release. * Patent Pending
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D., of Global Med Technologies,
Inc., +1-303-238-2000; or Investors, Paul M. Holm, +1-212-496-7238,
, for Global Med Technologies, Inc. Web site:
http://www.globalmedtech.com/
Copyright